CN Bio PhysioMimix Organ-on-a-Chip data supports Inipharm’s INI-822 for metabolic liver disease treatment now in clinical testing

The EC granted approval for Bristol Myers Squibb’s Camzyosb based on the positive safety and efficacy data from two Phase III trials. Credit: Bristol-Myers Squibb

SAN ANTONIO — Numerous studies and clinical evaluations have yet to uncover the etiology of post-orgasmic illness syndrome (POIS), which almost exclusively affects “people with